Pharmerica Revenue, Profits - PMC Annual Income Statement

Add to My Stocks
$29.05 $0 (0%) PMC stock closing price Aug 18, 2017 (Closing)

Fundamental analysis of PMC stock involves analyzing its financial statements, apart from checking the Pharmerica stock price The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from $2.03B to $2.09B and how operating and non operating activities have impacted the PMC stock. 2016 revenue is $2.09B and has increased from $2.03B year on year as is evident when you compare the latest figures in the latest Pharmerica profit and loss statement with those of the prior corresponding period. (See also:Pharmerica assets and Pharmerica free cash flow) Pharmerica revenue for 2016 is $2.09B. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
Pharmerica Net Sales or Revenues
2.09B2.03B1.89B1.76B1.83B2.08B1.85B1.84B1.95B1.22B
Cost Of Goods Sold (COGS)1.77B1.69B1.56B1.43B1.53B1.79B1.61B1.57B1.66B1.04B
Pharmerica Gross Profit
326M335.1M339.3M327.2M300.2M293.3M240.3M272.29M284.6M173.8M
Research & Development Expense----------
Selling General & Admin Expense253.9M252.7M288.8M256M239.1M235.3M195.2M192.8M255.6M141.4M
Income Before Depreciation Depletion Amortization72.1M82.39M50.5M71.2M61.09M58M45.1M79.49M29M32.4M
Depreciation Depletion Amortization33.7M28.6M20.1M15.4M12.3M11M9.3M9M6.5M5M
Non Operating Income---4.3M-------57.7M
Interest Expense9.5M6.6M9.9M10.6M10M8.8M3.6M9.4M14.2M7.2M
Pharmerica Pretax Income
28.9M47.2M16.2M45.2M38.8M38.2M32.2M61.1M8.3M-37.5M
Provision for Income Taxes7.3M12.1M9.4M26.3M15.9M14.8M13M18.9M3.3M-13.4M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations21.6M35.1M6.8M18.9M22.9M23.4M19.2M42.2M5M-24.1M
Extraordinary Items & Discontinued Operations----------
Pharmerica Net Income (Profit/Loss)
21.6M35.1M6.8M18.9M22.9M23.4M19.2M42.2M5M-24.1M
Average Shares used to compute Diluted EPS31.16M30.77M30.65M30.08M29.9M29.47M30.13M30.4M30.19M21.33M
Average Shares used to compute Basic EPS30.7M30.36M29.98M29.6M29.47M29.34M30.01M30.27M30.1M21.33M
Income Before Nonrecurring Items60.55M47.1M46.03M49.58M37.85M35.43M27.9M39.48M28.73M13M
Income from Nonrecurring Items-38.95M-12M-39.23M-30.68M-14.95M-12.03M-8.7M2.72M-23.73M-37.1M
Pharmerica Earnings Per Share Basic Net
0.701.160.230.640.780.800.641.390.17-1.13
Pharmerica Earnings Per Share Diluted Net
0.691.140.220.630.770.790.641.390.17-1.13
EPS Diluted Before Nonrecurring Items1.941.531.501.651.271.200.931.300.950.61
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

1:29
PMC
It is very helpful to read a report on Pharmerica stock analysis. An investor must check the following items in an income statement:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that PMC stock has a topline or revenue of $2.09B for 2016 as per this Pharmerica revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Pharmerica try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Pharmerica historical stock prices to check how the price has moved with time. .

Pharmerica Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
39.2570
PS ratio (
price sales ratio
)
0.4141
Operating margin
2
Net profit margin
0.8
Dividend yield
0%